ArthroCare Q1 Earnings Miss Ests; Revs In Line - Analyst Blog

ArthroCare Corporation Reports Q1 EPS of $0.32 vs $0.36 Est; Revenue of $96.10M vs $95.80M Est

MedTech's Partial Tax Repeal: Is It Enough? - Zacks Analyst Interviews

MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook

Varian Medical Systems Settles Patent Dispute - Analyst Blog

Thoratec Slapped with Class I Recall for HeartMate Controller - Analyst Blog

Balanced View on Cyberonics - Analyst Blog

ArthroCare Corporation Reports Q4 EPS of $0.30 vs $0.39 Est; Revenue of $101.70M vs $100.65M Est

Benzinga's M&A Chatter for Monday February 3, 2014

Market Wrap For February 3: Bears In Complete and Absolute Control

Mid-Afternoon Market Update: Markets Continue to Decline on Disappointing ISM Number Among Other Fac

Mid-Day Market Update: Dow Tumbles 250 Points; Ford Shares Slip On Weak Sales Report

Mid-Morning Market Update: Markets Drop; Smith & Nephew To Acquire ArthroCare For $48.25/Share

Benzinga's Top #PreMarket Gainers

US Stock Futures Flat Ahead Of Economic Data

Smith & Nephew To Acquire ArthroCare For $1.7B

Benzinga's Volume Movers

ArthroCare Corporation Reports Q2 EPS of $(0.27) Which May Not Compare $0.34 Est; Revenue of $92.10M

ArthroCare Buys ENTrigue Surgical for $45M in Cash

ArthroCare Announces Acquisition of ENTrigue Surgical, Inc.

ArthroCare Corporation Reports Q4 EPS of $0.30 vs $0.36 Est; Revenue of $96.60M vs $93.78M Est

Arthrocare Reports Q2 EPS $0.34 vs $0.37 Est; Revenues $91.7M vs $93.18M Est

Arthrocare Reports Q1 EPS $0.36 vs $0.34 Est; Revenues $92.9M vs $88.21M Est

ArthroCare Down 18% After Missing Earnings Estimates

UPDATE: Jefferies Downgrades ArthroCare to Hold

Canaccord Maintains Buy Rating and $43.50 PT on Arthocare

ArthroCare Announces Agreement in Principle to Settle Securities Class Action

UPDATE: Jefferies Lowers PT to $32 on ArthroCare

Earnings Preview: Stryker's EPS, Revenue Expected to Rise

ArthroCare Receives FDA Clearance for SpeedLock Knotless Fixation Device

NeuroTherm Acquires ArthroCare's Parallax and Contour Product Lines

ArthroCare Receives FDA Clearance for Spartan 6.5 Needled Suture Implant

ArthroCare Receives FDA Clearance for Parallax Contour-enhanced Vertebral Augmentation Device

Jefferies Raises Price Target On ArthroCare (NASDAQ: ARTC)

Benzinga's Volume Movers (KVHI, REGN, ARTC, AAWW)

ArthroCare Reports Q4 EPS of $0.30

ArthroCare Announces Fourth Quarter and Full Year 2010 Financial Results Feb. 14

Benzinga's Volume Movers (WFMI, IPGP, ARTC, DIOD)

Benzinga's Volume Movers (ARTC, KSWS, SMSI, ROSE)

ArthroCare Receives FDA Clearance for SpeedFix

ArthroCare Reports Third Quarter EPS of $.25

A Peek Into The Market Before The Trading Starts

ArthroCare Receives FDA Clearance for Spartan PEEK Suture Implant

FDA Clears ArthroCare Device - Analyst Blog

ArthroCare Receives FDA Clearance for Parallax Contour Vertebral (ARTC)

ArthroCare to Present at UBS Global Life Sciences Conference

ArthroCare Cuts Costs, Buy Rating Maintained

Arthrocare Tops Estimates By 3c

Benzinga’s Volume Movers (EVVV, PANL, QCOR, ARTC)

Movers And Shakers For March 16 (ATHN, ARTC, AVII, BNHN, CLF, HOG, MGM, BPOP, SONC, CLUB)